14 Biotech Stocks Facing FDA Approval

14 Biotech Stocks Facing FDA Approval

Submitted by admin on April 7, 2010 - 10:01am
Source: 
TheStreet.com
News Tags: 
Cell Therapeutics
Pozen
AstraZeneca
Dendreon
InterMune
Questcor Pharmaceuticals
Novartis
Biogen Idec
Teva Pharmaceuticals
Merck Serono
Savient
Javelin
Alexza
Human Genome
Jazz Pharmaceuticals
Arena Pharmaceuticals
Vivus
Biodel
Headline: 
14 Biotech Stocks Facing FDA Approval

Do Not Allow Advertisers to Use My Personal information